- ►onlinejacc.org M Pfisterer, HP Brunner-La Rocca, PT Buser, … - Journal of the American College of Cardiology, 2006 - Elsevier We sought to define the incidence of late clinical events and late stent
thrombosis in patients treated with drug-eluting (DES) versus bare-metal stents
(BMS) after the discontinuation of clopidogrel as well as their timing and ... Cited by 392 - Related articles - BL Direct - All 11 versions
- ►onlinejacc.org DJ Angiolillo, E Bernardo, C Ramírez, MA … - Journal of the American College of Cardiology, 2006 - Elsevier Insulin inhibits platelet aggregation by suppressing the P2Y 12 pathway.
However, T2DM patients have a loss of responsiveness to insulin that leads to
upregulation of the P2Y 12 pathway, increased platelet reactivity, and ... Cited by 79 - Related articles - BL Direct - All 23 versions
PM Ho, ED Peterson, L Wang, DJ Magid, SD … - Jama, 2008 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context It is unknown ... Cited by 71 - Related articles - BL Direct - All 4 versions
- ►onlinejacc.org DJ Angiolillo, E Bernardo, M Sabaté, P … - Journal of the American College of Cardiology, 2007 - Elsevier Type 2 diabetes mellitus patients have increased platelet reactivity compared
with nondiabetic patients. Whether HPR assessed in T2DM while in their
steady-state phase of dual antiplatelet therapy is associated with an ... Cited by 62 - Related articles - BL Direct - All 33 versions
- ►onlinejacc.org DR Holmes, DJ Kereiakes, WK Laskey, A … - Journal of the American College of Cardiology, 2007 - Elsevier Stent thrombosis (ST) after percutaneous coronary intervention has been the
focus of intense interest because of its attendant morbidity and mortality.
There is controversy about several facets of the problem. These include the ... Cited by 56 - Related articles - BL Direct - All 31 versions
- ►onlinejacc.org M Valgimigli, G Campo, C Arcozzi, P Malagutti, … - Journal of the American College of Cardiology, 2007 - Elsevier We sought to investigate whether the previously reported midterm clinical
benefit of planned sirolimus-eluting stent (SES) implantation in patients with
ST-segment elevation myocardial infarction (STEMI) was maintained over a 24- ... Cited by 37 - Related articles - BL Direct - All 29 versions
SD Wiviott - The American journal of cardiology, 2006 - Elsevier Dual antiplatelet therapy represents an important advance for patients with
established cardiovascular disease. Variable platelet response and potential
resistance to therapy have emerged with aspirin and clopidogrel. There is ... Cited by 29 - Related articles - All 5 versions
PW Serruys, J Daemen - Circulation, 2007 - Am Heart Assoc Late stent thrombosis (ST) is for us an old foe that we have tracked repeatedly
throughout the history of interventional cardiology. In 1991, we made headlines
by publishing in the New England Journal of Medicine a rate of early and ... Cited by 27 - Related articles - All 3 versions
- ►diabetesjournals.org T Geisler, N Anders, M Paterok, H Langer, K … - Diabetes Care, 2007 - Am Diabetes Assoc Type 2 diabetes is accompanied by platelet function disorders leading to an
accelerated process of atherosclerosis and increased risk for atherothrombotic
complications (1–4). Previous data (5,6) suggest a worse outcome for ... Cited by 26 - Related articles - BL Direct - All 9 versions
VL Serebruany - The American journal of cardiology, 2007 - Elsevier Numerous randomized trials have indicated the benefits of clopidogrel either as
an alternative 1 or as an adjunct 2 to aspirin for the secondary prevention of
acute vascular events, including absolute mortality reduction in the ... Cited by 18 - Related articles - All 13 versions
